Drug shows high effectiveness against testicular cancer
A platinum based drug trial at Memorial Sloan Kettering reported 95 percent remission among 29 testicular cancer patients with two thirds achieving complete remission after eight months. Researchers noted potential fertility impact and kidney related toxicity, but cited improved survival versus past treatments.
MENTIONED IN THIS ARTICLE
Petersburg
Fla
Irwin H. Krakoff
Memorial Stuan-Kettering Cancer Center
New York
Krakoff
United States
Sloan-Kettering
Also Mentioned on This Page
American Cancer Society
EPA
The
Environmental Protection Agency
Angelites
R.G. Barry
Lorain
Elyria
Lorain County
California
Dorip
Reg
Maxwell House Coffee
Boston
Edwards
Hamburger
Farm Fresh
Gov't. Insp
Broilers
Little Anduere
Swift's Brown
Link Sausage